136 related articles for article (PubMed ID: 2040531)
1. Evaluation of circulating tumor necrosis factor-alpha in patients with gynecological malignancies.
De Jaco P; Asselain B; Orlandi C; Fridman WH; Teillaud JL
Int J Cancer; 1991 May; 48(3):375-8. PubMed ID: 2040531
[TBL] [Abstract][Full Text] [Related]
2. [Plasmafibronectin in case of tumors of the female genital system].
Tatra G; Nasr F
Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
[TBL] [Abstract][Full Text] [Related]
3. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer].
Kondera-Anasz Z; Mielczarek-Palacz A; Switała J
Ginekol Pol; 2003 Sep; 74(9):761-6. PubMed ID: 14674121
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer.
Nishikawa R; Suzumori N; Nishiyama T; Nishikawa H; Arakawa A; Sugiura-Ogasawara M
Eur J Gynaecol Oncol; 2012; 33(2):138-41. PubMed ID: 22611950
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen.
Inaba N; Negishi Y; Fukasawa I; Okajima Y; Ota Y; Tanaka K; Matsui H; Iwasaki H; Sudo H; Tanaka N
Tumour Biol; 1995; 16(6):345-52. PubMed ID: 7569681
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
7. Serum prealbumin, transferrin and alpha-1-acid glycoprotein in patients with gynecological carcinomas.
Tosner J; Krejsek J; Louda B
Neoplasma; 1988; 35(4):403-11. PubMed ID: 3141823
[TBL] [Abstract][Full Text] [Related]
8. Early hemostatic disorders in patients with gynecologic tumors.
Di Roberto P; Benedetti Panici P; Scambia G; Laghi F; Margariti PA; Mancuso S; Bompiani A
Eur J Gynaecol Oncol; 1986; 7(2):109-12. PubMed ID: 2941303
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
[TBL] [Abstract][Full Text] [Related]
10. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.
Suzuki M; Ohwada M; Sato I; Nagatomo M
Oncology; 1995; 52(2):128-33. PubMed ID: 7854772
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
Suzuki H; Miyoshi T; Sasaki H; Yoshida T
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
[No Abstract] [Full Text] [Related]
13. The diagnostic value of serum copper/zinc ratio in gynecological tumors.
Brandes JM; Lightman A; Drugan A; Zinder O; Cohen A; Itskovtiz J
Acta Obstet Gynecol Scand; 1983; 62(3):225-9. PubMed ID: 6624394
[TBL] [Abstract][Full Text] [Related]
14. Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women.
Yamashita K; Hayashi H; Mure K; Ishikawa M; Shimizu T
Cancer; 1986 Jan; 57(1):69-74. PubMed ID: 3940624
[TBL] [Abstract][Full Text] [Related]
15. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
[TBL] [Abstract][Full Text] [Related]
16. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.
Elsässer-Beile U; von Kleist S; Sauther W; Gallati H; Mönting JS
Br J Cancer; 1993 Jul; 68(1):32-6. PubMed ID: 8318418
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
Restaino A; Fanizza G; Battarino O
Eur J Gynaecol Oncol; 1986; 7(3):183-5. PubMed ID: 3780759
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid composition of serum and tissue lipids in benign and malignant gynecologic disease.
De Alvarez RR; Castellanos H; O'Leary DK; Jahed F
Am J Obstet Gynecol; 1969 May; 104(2):230-46. PubMed ID: 5781897
[No Abstract] [Full Text] [Related]
19. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
20. Circulating IgE levels in patients with gynecological tumors.
Tatra G; Lasnik E
Klin Wochenschr; 1985 Aug; 63(15):699-701. PubMed ID: 4046497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
